Carlyle backs global health research in latest investment

The Carlyle Group made a strategic growth investment and will acquire a majority stake in TriNetX, a global health research network focused on clinical research to bring new therapies . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.